It is a pharma public limited company based in Moga, Punjab, India, established in 2018.
2018 | Moga, Punjab, India | ActiveDr Mendeleev Research And Formulation Limited, a active public limited company, was established on 26 December 2018 in Moga, Punjab, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24290PB2018PLC048830. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹2.50 M.
Its leadership includes Avtar Singh Saggu (Director), Baljeet Kaur (Director), Muneet Singh Saggu (Director). Past directors included Avtar Singh Saggu. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C/O Avtar Singh Saggu S/O Karam Singh, Ishwar Chowk,, Moga, Punjab, 142001.
U24290PB2018PLC048830
048830
26 December 2018
₹5.00 M
₹2.50 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Dr Mendeleev Research And Formulation Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Avtar Singh Saggu | Director | 26 Dec 2018 | Current |
| Baljeet Kaur | Director | 26 Dec 2018 | Current |
| Muneet Singh Saggu | Director | 26 Dec 2018 | Current |
| Parveen | Director | 26 Dec 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 31 Dec 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dr Mendeleev Research And Formulation Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 56.78% increase in profit. The company's net worth dipped by a decrease of 0.04%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
In 2024, Dr Mendeleev Research And Formulation had a promoter holding of 94.60% and a public holding of 5.40%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Dr Mendeleev Research And Formulation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Dr Mendeleev Research And Formulation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr Mendeleev Research And Formulation's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Dr Mendeleev Research And Formulation Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Dr Mendeleev Research And Formulation Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was documented.
The activity Avtar Singh Saggu was appointed as a Director was appointed as a Director on 26 Dec 2018 & has been associated with this company since 6 years 11 months . was completed.
Progress on Baljeet Kaur was appointed as a Director was appointed as a Director on 26 Dec 2018 & has been associated with this company since 6 years 11 months . was documented.
Muneet Singh Saggu was appointed as a Director was appointed as a Director on 26 Dec 2018 & has been associated with this company since 6 years 11 months . was recorded as a recent event.
The activity Parveen was appointed as a Director was appointed as a Director on 26 Dec 2018 & has been associated with this company since 6 years 11 months . was completed.
The CIN of Dr Mendeleev Research And Formulation Limited is U24290PB2018PLC048830.
Dr Mendeleev Research And Formulation Limited is headquartered at C/O Avtar Singh Saggu S/O Karam Singh, Ishwar Chowk,, Moga, Punjab, 142001.
Dr Mendeleev Research And Formulation Limited was incorporated on 26 December 2018.
The current directors of Dr Mendeleev Research And Formulation Limited are
The primary industry of Dr Mendeleev Research And Formulation Limited is Pharma.
Dr Mendeleev Research And Formulation Limited is unlisted.
The authorized capital of Dr Mendeleev Research And Formulation Limited is ₹5.00 M, and the paid-up capital is ₹2.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX